Señales en vivo de 086450.KQ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 02:30):

Stats
Volumen de hoy	138 656
Volumen promedio	191 121
Capitalización de mercado	721.46B
EPS	KRW0 ( 2024-03-14 )
Próxima fecha de ganancias	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW25.70 (0.15%)

Volumen Correlación

Largo: 0.28 (neutral)

Corto: -0.54 (weak negative)

Signal:(60.14) Neutral

DongKook Pharmaceutical Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DongKook Pharmaceutical Correlación - Moneda/Commodity

-0.73
( moderate negative )

-0.55
( weak negative )

0.04
( neutral )

-0.58
( weak negative )

0.64
( weak )

DongKook Pharmaceutical Finanzas

Annual	2023
Ingresos:	KRW730.99B
Beneficio Bruto:	KRW405.04B (55.41 %)
EPS:	KRW1 073.13

FY	2023
Ingresos:	KRW730.99B
Beneficio Bruto:	KRW405.04B (55.41 %)
EPS:	KRW1 073.13

FY	2022
Ingresos:	KRW661.65B
Beneficio Bruto:	KRW375.19B (56.71 %)
EPS:	KRW1 203.46

Financial Reports:

No articles found.

DongKook Pharmaceutical

DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.